FUNCTIONAL INTERACTIONS BETWEEN INTERLEUKIN-4, INTERLEUKIN-2, AND TUMOR NECROSIS FACTOR-ALPHA FOR LYMPHOKINE-ACTIVATED KILLER-CELL GENERATION

被引:1
|
作者
BLAY, JY [1 ]
BRANELLEC, D [1 ]
ROBINET, E [1 ]
GAY, F [1 ]
CHOUAIB, S [1 ]
机构
[1] INST GUSTAVE ROUSSY,IMMUNOL LAB,CNRS,UA 1156,RUE CAMILLE DESMOULINS,F-94805 VILLEJUIF,FRANCE
关键词
IL‐2; IL‐4; LAK; TNF;
D O I
10.1002/jcla.1860040111
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The purpose of the present study was to explore the interaction between interleukin‐2 (IL‐2), interleukin‐4 (IL‐4), and tumor necrosis factor‐a (TNF) on the differentiation of human large granular lymphocytes (LGL) into lymphokine‐activated killer cells (LAK). The data show that recombinant human IL‐4 (100‐1,000 U/ml) was able to induce the differentiation of human LGL into LAK effectors. The levels of the IL‐4‐induced cytotoxicity are significantly lower than those observed after stimulation of LGL by optimal doses of IL‐2. This LAK activity generation by IL‐4 was not associated with LGL proliferation. When TNF was added in LGL culture in the presence of sub‐optimal concentrations of IL‐4, the lytic capacity of the activated killer cells was significantly enhanced, suggesting an apparent synergy between these two factors. Most interestingly, our data indicate that exogenous TNF can partially overcome the known inhibitory effect of IL‐4 on IL‐Pinduced LGL differentiation into LAK effectors. These findings suggest a role for TNF in the process of LAK induction. Copyright © 1990 Wiley Periodicals, Inc., A Wiley Company
引用
收藏
页码:54 / 58
页数:5
相关论文
共 50 条
  • [21] TUMOR NECROSIS FACTOR-ALPHA ENHANCES THE CYTOLYTIC AND CYTOSTATIC CAPACITY OF INTERLEUKIN-2 ACTIVATED KILLER CELLS
    MATOSSIANROGERS, A
    BROWNE, C
    TURKISH, M
    OBYRNE, P
    FESTENSTEIN, H
    BRITISH JOURNAL OF CANCER, 1989, 59 (04) : 573 - 577
  • [22] CHARACTERIZATION AND MODULATION OF HUMAN LYMPHOKINE (INTERLEUKIN-2) ACTIVATED KILLER-CELL INDUCTION
    HOYER, M
    MEINEKE, T
    LEWIS, W
    ZWILLING, B
    RINEHART, J
    CANCER RESEARCH, 1986, 46 (06) : 2834 - 2838
  • [23] LYMPHOKINE ACTIVATED KILLER-CELL AND INTERLEUKIN-2 INHIBITORS - THEIR ROLE IN ADOPTIVE IMMUNOTHERAPY
    EGGERMONT, AMM
    SUGARBAKER, PH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 363 - 363
  • [24] TOXICITY OF IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    MIER, JW
    ARONSON, FR
    NUMEROF, RP
    VACHINO, G
    ATKINS, MB
    PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1988, 7 (06): : 459 - 476
  • [25] SYNERGY OF HUMAN RECOMBINANT INTERLEUKIN-1 WITH INTERLEUKIN-2 IN THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS
    CRUMP, WL
    OWENSCHAUB, LB
    GRIMM, EA
    CANCER RESEARCH, 1989, 49 (01) : 149 - 153
  • [26] THE ROLE OF EOSINOPHILS IN INTERLEUKIN-2/LYMPHOKINE-ACTIVATED KILLER (LAK) CELL THERAPY
    ISHIMITSU, T
    IWASAKI, K
    TORISU, M
    FASEB JOURNAL, 1992, 6 (04): : A1152 - A1152
  • [27] INTERLEUKIN-2 LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY OF NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE
    BERNSTEIN, ZP
    VAICKUS, L
    FRIEDMAN, N
    GOLDROSEN, MH
    WATANABE, H
    RAHMAN, R
    ARBUCK, SG
    SWEENEY, J
    VESPER, D
    HENDERSON, ED
    ZEFFREN, J
    DENNIN, RA
    LEVITT, D
    FOON, KA
    JOURNAL OF IMMUNOTHERAPY, 1991, 10 (02): : 141 - 146
  • [28] THE INFLUENCE OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER-CELL INFUSIONS ON THE TOXICITY AND ANTITUMOR EFFECT OF REPETITIVE CYCLES OF INTERLEUKIN-2
    ALBERTINI, MR
    SOSMAN, JA
    HANK, JA
    MOORE, KH
    BORCHERT, A
    SCHELL, K
    KOHLER, PC
    BECHHOFER, R
    STORER, B
    SONDEL, PM
    CANCER, 1990, 66 (12) : 2457 - 2464
  • [29] INTERLEUKIN-2 OR AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER-CELL TREATMENT OF MALIGNANT GLIOMA - PHASE-I TRIAL
    JACOBS, SK
    WILSON, DJ
    KORNBLITH, PL
    GRIMM, EA
    CANCER RESEARCH, 1986, 46 (04) : 2101 - 2104
  • [30] CHARACTERISTICS OF INTERLEUKIN-6-ENHANCED LYMPHOKINE-ACTIVATED KILLER-CELL FUNCTION
    IHO, S
    SHAU, H
    GOLUB, SH
    CELLULAR IMMUNOLOGY, 1991, 135 (01) : 66 - 77